
Higher education company Strategic Education (NASDAQ: STRA) met Wall Street’s revenue expectations in Q3 2026, with sales up 1.6% year on year to $325.1 million. Its non-GAAP profit of $1.72 per share was 11.9% below analysts’ consensus estimates.
Is now the time to buy STRA? Find out in our full research report (it’s free for active Edge members).
Strategic Education (STRA) Q3 2026 highlights:
- Revenue $325.1 million vs S&P analysts’ estimates of $326.7 million (1.6% year-on-year growth, in line)
- Adjusted EPS $1.72 vs S&P analysts’ expectations of $1.95 (11.9% miss)
- Adjusted EBITDA $71.03 million vs analyst estimates of $75.73 million (21.9% margin, 6.2% miss)
- Operating margin -26.9%, down from 11.6% in the same quarter last year
- Domestic students down 915 year on year
- Market capitalization $1.33 billion
StockStory’s take
Strategic Education’s third quarter was marked by a negative market reaction, as the company’s non-GAAP profit fell short of Wall Street’s expectations despite revenue coming in line. Management attributed the mixed results to continued strength in its U.S. healthcare and Education Technology Services segments, which were offset by significant challenges in its Australia business. CEO Karl McDonnell described the international enrollment environment as more severe than anticipated, citing tightened government restrictions and a sharp decline in new visa approvals for international students.
Looking forward, Strategic Education’s outlook is shaped by increased investment in high-growth segments, particularly U.S. healthcare and Education Technology Services, as well as domestic expansion in Australia. The company expects these initiatives to pressure margins in the short term but drive higher growth rates over time. McDonnell said, "We have a high degree of confidence in [these investments'] ability to return the company to its notional growth rates in 2028 and beyond." Management also noted that ongoing regulatory challenges in Australia and evolving student acquisition channels remain areas of close focus.
Key insights from management’s remarks
Management pointed to strong performance in healthcare and education technology, offset by regulatory-driven declines in Australia, as the main themes influencing the latest quarter’s results.
- Healthcare segment drives growth: U.S. healthcare enrollment grew 9%, now representing 54% of U.S. Higher Education students. New programs in nursing and radiologic technology saw demand exceed initial expectations, and management plans increased investment to support future expansion.
- Education Technology Services expansion: Education Technology Services segment delivered 12% revenue growth, with Sophia Learning subscribers up 22%. Management plans to accelerate the product roadmap and invest more heavily in this segment next year, even if it temporarily reduces segment margins.
- Australia faces regulatory headwinds: Enrollment in Australia dropped 9%, mainly due to strict government restrictions on international students and changes to student transfer policies. Management recorded a $134 million non-cash impairment and is shifting focus to domestic enrollment, which grew 9% in the quarter.
- Employer partnerships strengthen: Employer-affiliated enrollment in U.S. Higher Education rose to 35%, and Workforce Edge now covers 4 million employees through 83 corporate agreements. These partnerships are viewed as key to stabilizing enrollment trends and supporting growth.
- Cost efficiency and capital allocation: Operating expense growth was held below 1% company-wide, and productivity initiatives offset some of the impact from increased investments. Strategic Education repurchased $28.5 million in shares and ended the quarter with $139 million in cash and no debt.
Drivers of future performance
Strategic Education’s outlook centers on expanded investment in healthcare and technology, while navigating persistent regulatory risks and moderating enrollment trends.
- Growth investment and margin trade-off: Management expects to increase spending in Education Technology Services and U.S. healthcare programs in the coming year, aiming for long-term revenue acceleration. However, these investments are likely to compress segment operating margins in the near term as new faculty and program infrastructure are added.
- Australia domestic focus and campus expansion: The company’s growth plan for Australia relies on expanding domestic enrollment, new health science programs, and opening a Perth campus. Management has tempered expectations for international student recovery, instead prioritizing the domestic market to drive gradual enrollment growth through 2027 and into 2028.
- Evolving student acquisition and regulatory monitoring: Management continues to monitor the impact of new digital search methods, such as AI-driven platforms, and any changes in government policy that could affect student demand. They acknowledge uncertainty about how long regulatory restrictions in Australia will persist, and are adapting marketing and admissions approaches to maintain relevance across all student acquisition channels.
Catalysts in upcoming quarters
In the coming quarters, the StockStory team will be tracking (1) the pace of enrollment growth in U.S. healthcare programs and how quickly new investments translate into student gains, (2) the impact of domestic campus expansions and program launches on Australia segment performance, and (3) the effect of continued investments in Education Technology Services on both subscriber growth and profitability. We will also monitor regulatory developments in Australia and shifts in student acquisition patterns tied to digital channels.
Strategic Education currently trades at $59.61, down from $74.32 just before the earnings. Is there an opportunity in the stock? See for yourself in our full research report (it’s free).
High quality stocks for all market conditions
ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI is taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.
Our AI system flagged Palantir before it ran 1,662% between October 2022 and February 2026. AppLovin before it ran 753% between February 2024 and February 2026. Nvidia before it ran 1,178% between January 2023 and February 2026. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.
Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+1,154% between June 2020 and June 2025). Find your next big winner with StockStory today.
